Jeffrey Shippy, Founder and CEO of AudacityIB, Appointed as Senior Executive at DxNow (Published August 2020)

PRESS RELEASE ISSUED AUGUST 13, 2020

Jeffrey Shippy, Founder and CEO of AudacityIB, an emerging financial advisory and transaction consulting firm focused on founder-owned business transformations and exits, has been appointment as a key executive at DxNow, a rapidly-growing commercial provider of FDA-cleared biotech devices developed in partnership with Stanford Medicine, Harvard Medical School, and Brigham & Women’s Hospital.

Mr. Shippy will serve as EVP and CFO to help the Founders and Executive Team transform and ready the company for its next stage of growth and help guide the Company to deliver continued outsized revenue growth and maximum shareholder value.

ABOUT AUDACITYIB:

Founded in 2020, AudacityIB helps transform and develop founder-owned companies and ready them for potential future exits. When the time comes for an exit, AudacityIB also serves as exclusive M&A broker to drive a successful transaction outcome. The firm also provides hands-on daily operations leadership in top executive roles with select clients.

ABOUT DXNOW:

DxNow is a commercial provider of FDA-cleared biotech devices developed in partnership with Stanford Medicine, Harvard Medical School, and Brigham & Women’s Hospital, originating from the Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs). The technology is based on patented, novel microfluidics that has benefits not only within the fertility sector, but also across broader women's health and life sciences sectors, as well as veterinary markets.